1Research Scholar, Department of Chemistry, School of Science, Sandip University, Nashik, Maharashtra, India, 422213
2Assistant Professor, Department of Chemistry, School of Science, Sandip University, Nashik, Maharashtra, India, 422213
3Department of Process Research and Development, Megafine Pharma (P) Ltd., 201, Lakhmapure, Dindori, Nashik, Maharashtra, India, 422 202
4Research Scholar, Department of Chemistry, School of Science, Sandip University, Nashik, Maharashtra, India, 422213
5Research Scholar, Department of Chemistry, School of Science, Sandip University, Nashik, Maharashtra, India, 422213
*Corresponding Author E-mail: leena.patil@sandipuniversity.edu.in
Online Published on 30 October, 2025.
Manufacturing process reported for the synthesis of Lurasidone hydrochloride are uneconomical, inefficient and practically difficult to operate at industrial scale due to their incapability to control process related and isomeric impurities, more no of synthesis steps, high temperature reaction, huge solvent volume and chromatographic purification makes the process uneconomical, hence need develop cost effective and efficient process for the synthesis of lurasidone hydrochloride. Lurasidone has six chiral centres, and it is necessary to quantify the concentration level of each isomer and specify limits for all isomeric components, impurities, and contaminants for effective application of drugs proposed for intended use. The present work explains about the lurasidone hydrochloride process free from optical isomers and focused on the root of formation of different isomers. Control strategy designed for KRM, KSM, intermediate and finished API. This work also explains the effectiveness of proposed control strategy from laboratory to commercial scale.
Optical isomer, Key staring material, (1R, 2R)-1, 2-cyclohexanedimethanol, 3-piperazin-1-yl-1, 2-benzisothiazole, (3aR, 4S, 7R, 7aS)-hexahydro-4, 7-methano-2H-isoindole-1, 3-dione, Lurasidone HCl